Cure rates are climbing, and so is the complexity of getting there. Dr Yara Abdou takes a closer look at optimizing HER2+ early-stage breast cancer therapy.

Extensive family clustering across early- and late-onset cases shaped perceived inevitability of disease and underscores the importance of hereditary risk assessment. Initial management followed ...

Upon receiving a breast cancer diagnosis, patients will soon receive a pathology report that informs them about the stage their cancer is in. Upon receiving a breast cancer diagnosis, patients will ...

Forbes contributors publish independent expert analyses and insights. Dilan Gomih is a well-being expert focused on workplace performance. Breast cancer screening isn’t just a medical issue. It’s a ...

The way women are screened for breast cancer in Australia is changing. According to a newly released review, this means ...

A combination of two immunotherapy drugs showed encouraging activity when added to standard chemotherapy given before surgery ...